PDF-associated paralytic polio (VAPP) and

Fact Sheet x2013 February 2015 Vaccine vaccine derived poliovirus VDPV The oral polio vaccine OPV is an extremely safe and effective tool for immunizing children against polio xF0. Page What is paralytic shellfish poisoning? The amount of toxinincreases when water conditions are favorable. However, the exact Which seafoodpose a PSP riskto humans?All bivalve molluscan shellfish AGENT FACTORS. :. Agent: . Poliovirus, . - RNA virus, serotype –1,2,3. - Most outbreaks – type 1. -Survive for long periods in external environment in cold climate. Part 1: Technical Rationale for IPV Introduction and OPV Withdrawal. GPEI Accomplishment . Significant Decline in Paralysis Due to WPVs, 1988 to 2013*. Poliovirus Types. IPV. Number of Cases of cVDPV-related Polio Exceeds the Number of Cases of WPV. February 2015Vaccine-associated paralytic polio VAPP and vaccine-derived poliovirus VDPV The oral polio vaccine OPV is an extremely safe and effectivetool for immunizing children against polioOver the Introduction. The cause of poliomyelitis. Polios: gray. Myelos. : marrow or spinal cord. Global eradication is anticipated in 21. st. century. History. Exists from antiquity. 1890: First described formally by . Epidemiology . Paralysis is the most devastating effect of polio virus infection. Although 90-95 % infection-subclinical. Eradicated in most of countries except Nigeria, Afghanistan and Pakistan. Universal vaccination strategy and improved sanitation: key factor in eradication. LEENA MOSTAFA. What is polio?. Poliomyelitis, often called polio or infantile paralysis, is an . infectious disease.  caused by the . poliovirus. . In about 0.5% of cases there is . muscle weakness. Stephen Zabor. Iron Lung. In 2017 there were still at least 3 people in an iron lung.. In 1959, there were 1,200 people using tank respirators in the United States.. 1955 -- Jonas Salk’s vaccine approved. Dr. Ananda S. Bandyopadhyay. ADVAC Webinar; May 26, 2020. Does it work ?. - Clinical Development Update. How would we use it ?. What is novel OPV2?. - Background. - Emergency Use Listing, Country Prioritization. Post - lateral sclerosis - similarities, differences and diagnostic dilemmas . Ewa Matyja, MD, PhD; Milena Laure - Kamionowska, MD Department of Neuropathology, Mossakowski Medical Research Centre, DATE: August 4 , 2022 TO : (LHDs) FROM : New York State Department of Health (NYSDOH), Division of Epidemiology Updates Since Last Advisory • NYSDOH is conducting enhanced surveillance activitie July 2021. Delivered by National Emergency Routine Immunisation Coordination Centre (NERICC). 2.0 Introduction to Polio End Game Strategy. Learning objectives. 2. At the end of the session participants should be able to:. National Primary Health Care Development Agency. July 2021. Delivered by National Emergency Routine Immunisation Coordination Centre (NERICC). Session Objectives. 2. By the end of this session, participants will be able to explain:. Transition Planning. Stephen Cochi, MD, MPH. Polio Legacy Management Group, GPEI. India Expert Advisory Group Meeting on Polio Eradication. 20 March 2015. Polio Endgame Strategic Plan 2013-18. Objective 1.